Insiders · Profile

Tullman Stephen A.

Director at Aclaris Therapeutics. Filing since 6 Apr 2018. CIK 0001654343

Company
Date
Role
Action
Shares
Amount
Of holding
4 Oct 2018
Director
Bought
7,100
$99.37K
4.2%
23 Aug 2018
Director
Bought
6,600
$98.98K
4.0%
15 Aug 2018
Director
Bought
6,250
$99.81K
4.0%
6 Apr 2018
Director
Bought
26,700
$441.62K
20.4%
4 decisions on file.